InvestLog
QGEN logo

QGEN

Qiagen N.V.NYSEHealthcare
$41.03+1.61%OpenMarket Cap: $8.46B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-13Deutsche Bank—Buy—
2026-02-06JP Morgan—Overweight—
2026-02-06Stifel—Hold—
2026-02-06Citigroup—Neutral—
2026-01-22Deutsche Bank—Hold—
2025-12-15Barclays—Overweight—
2025-12-11Citigroup—Neutral—
2025-10-02Barclays—Overweight—
2025-08-07UBS—Neutral—
2025-06-26B of A Securities—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$2.77$2.35B8
Sun Dec 31$3.02$2.49B4
Mon Dec 31$3.27$2.63B2
Tue Dec 31$3.54$2.77B2
QGEN | Qiagen N.V. Analyst Ratings & Price Target - InvestLog